Rheumatoid Arthritis Comorbidity: Bone Health in Men and African Americans
NCT ID: NCT00595894
Last Updated: 2023-09-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1745 participants
OBSERVATIONAL
2004-07-01
2013-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Registry for African Americans With Early Rheumatoid Arthritis
NCT00074555
Health Beliefs and Health Behaviors Among Minorities With Rheumatic Diseases
NCT00069342
Rheumatoid Arthritis and Osteosarcopenia: Associated Factors
NCT06889415
Gene-Environment Interactions in Rheumatoid Arthritis Autoimmunity Disease Severity
NCT00594451
Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiography
NCT01476956
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The Specific Aims of the study are to:
1. Determine baseline hip and lumbar spine bone density (BMD) values and osteopenia/osteoporosis prevalence among African American men and women with early RA and among male veterans with established RA.
2. Identify environmental factors and candidate alleles, which confer increased risk of reduced baseline BMD loss over time among African American men and women with early RA and among male veterans with established RA.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1 CLEAR participants - African Americans with early rheumatoid arthritis
CLEAR enrollees include African American patients with early rheumatoid arthritis, as defined using ACR criteria
No interventions assigned to this group
2 VARA participants - male veterans with established rheumatoid arthritis
VARA enrollees will include male veterans with established RA diagnosed using ACR criteria
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NIH
University of Nebraska
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ted R Mikuls, MD, MSPH
Role: PRINCIPAL_INVESTIGATOR
University of Nebraska
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Omaha Veteran's Affairs Medical Center
Omaha, Nebraska, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
National Institute of Health
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0028-03-ET
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.